Healthcare: Cancer is a heterogeneous and multifactorial disease. Among multiple factors, it may be caused by errors, or ...

Genetic testing is a vital tool in combating hereditary gynecologic cancers, enabling early detection and personalised care.

The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers focusing on maintaining ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

It was a shock for 30-year-old Georgie Bellette to find out she has a high risk of developing cancer, but her family is now ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

A recent study found that around 14,000 patients with cancer could have reduced risk of harmful side effects from cancer ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

A mum and daughter in Jersey are highlighting the importance of genetic testing as part of Breast Cancer Awareness Month. Ginny battled breast cancer three times, and after this, her and her daughter ...

Global Breast Cancer Screening Tests Market was valued at approximately USD 2.93 billion in 2023 and is projected to grow with a healthy CAGR of 54.3% over the forecast period 2024-2032. Read the ...

During breast cancer awareness month, researchers are taking a look at genetics to learn how likely someone’s cancer risk is.